Kura Oncology Inc

Research Kura Oncology Inc (KURA) on Bullrun: market cap USD 973.86M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKURA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 973.86M
• Financial periodFY2025
• RevenueUSD 67.48M
• Revenue growth25.2%
• Net income-USD 278.67M
• Free cash flow-USD 70.70M

Valuation Snapshot

latest market cap is USD 973.86M.

About Kura Oncology Inc

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications;

Frequently asked questions

What is Kura Oncology Inc's market cap?

Kura Oncology Inc's market capitalization is USD 973.86M.

What does Kura Oncology Inc do?

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor;